Medical Financial Hardships Shared in Cancer-Linked Crowdfunding Stories
By Elana Gotkine HealthDay Reporter
FRIDAY, Oct. 11, 2024 -- A considerable proportion of cancer-related crowdfunding stories share experiences of medical financial hardships and health-related social needs (HRSNs), according to a research letter published online Oct. 10 in JAMA Oncology.
Zhiyuan Zheng, Ph.D., from the American Cancer Society in Atlanta, and colleagues used a large natural language processing (NLP) model to examine unmet medical and social needs based on cancer-related fundraising stories extracted from the GoFundMe website from Jan. 1, 2021, to May 23, 2023.
A total of 91,113 cancer-related crowdfunding campaigns were identified and 24,002,700 words from their stories were analyzed. The researchers found that the proportions with NLP outputs for individual campaign characteristics were 19.6, 61.1, 5.1, 18.3, and 20.6 percent for age, sex, marital status, health insurance, and employment status, respectively. Most of the campaigns had NLP outputs for cancer type and treatments (79.0 and 52.6 percent, respectively). Of all the fundraiser stories, 25.5 and 24.1 percent, respectively, had NLP outputs for medical financial hardship and HRSNs, including employment or school disruptions; loss of income; or struggles with food, housing, transportation expenses, and monthly bills. Most fundraisers received some funds (99.5 percent), but few achieved their goals (11.4 percent). Manual checking of a sample of 50 fundraising stories showed accuracy of 95.7 percent within the NLP model.
"The study findings suggest that more than one-third of cancer-related crowdfunding campaigns explicitly mentioned medical financial hardship or HRSNs, underscoring the fragility of safety nets in the U.S.," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
TUESDAY, April 29, 2025 -- Patients with cancer aged 65 years and older receiving immune checkpoint inhibitors (ICIs) derive similar clinical outcomes as younger patients...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.